SaveRxCanada.to has expanded its prescription medication offerings to include Ozempic sourced from India, providing American patients with a lower-cost option amid continued increases in U.S. pharmacy prices. This development addresses growing concerns about prescription affordability in the United States, where cash-pay prices for Ozempic at retail pharmacies often range from $900 to more than $1,100 per pen, depending on dosage and location.
The international pharmacy service now offers Ozempic from India at prices starting at approximately $280 per pen, with additional savings available on multi-unit orders. According to pricing published on SaveRxCanada.to, patients may see potential savings of $700 or more per pen compared to typical U.S. retail pharmacy prices. Per-unit costs decrease further when multiple pens are ordered, offering an option for those seeking predictable pricing and longer-term planning.
Ozempic (semaglutide), manufactured by Novo Nordisk, is commonly prescribed in the United States for type 2 diabetes management. SaveRxCanada.to currently offers Ozempic in multiple prefilled pen strengths, allowing patients and healthcare providers to select the prescribed dosage. Available options include the Ozempic Prefilled Pen 0.25 mg (1.5 mL), Ozempic Prefilled Pen 0.5 mg (1.5 mL), and Ozempic Prefilled Pen 1 mg (3 mL).
A valid prescription is required for all Ozempic orders through the service. Patients may place orders online or speak with a representative by phone during business hours. All orders include free shipping, with product details clearly listing the country of origin and manufacturer. The company emphasizes prescription-only fulfillment and transparent pricing as key components of their service model.
This expansion comes as U.S. prescription prices continue to rise, making international pharmacy options increasingly attractive to patients seeking to better manage out-of-pocket healthcare expenses. SaveRxCanada.to has been in operation for 24 years, assisting patients with access to prescription medications through international pharmacy services while emphasizing transparency and customer support.
The availability of lower-cost Ozempic from India through established international pharmacy services represents a significant development for American patients managing chronic conditions. As prescription affordability remains a concern for many Americans, such options provide additional avenues for cost management while maintaining access to essential medications. The service's focus on price transparency and prescription-only fulfillment addresses common concerns about medication safety and legitimacy in international pharmaceutical markets.
